Free Trial
Yuan Zhi

Yuan Zhi Analyst Performance

Managing Director at B. Riley

Yuan Zhi is a stock analyst at B. Riley focused in the medical sector, covering 5 publicly traded companies. Over the past year, Yuan Zhi has issued 8 stock ratings, including strong buy and buy recommendations. While full access to Yuan Zhi's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Yuan Zhi's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
8 Last 0 Years
Buy Recommendations
100.00% 8 Buy Ratings
Companies Covered
5 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy12.5%1 ratings
Buy87.5%7 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

Out of 8 total stock ratings issued by Yuan Zhi at B. Riley, the majority (87.5%) have been Buy recommendations, followed by 12.5% Strong Buy.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
60.0% of companies on NASDAQ
3 companies
NYSE
40.0% of companies on NYSE
2 companies

Yuan Zhi, an analyst at B. Riley, currently covers 5 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
4 companies
80.0%
Business Services
1 company
20.0%

Yuan Zhi of B. Riley specializes in stock coverage within the Medical sector, with additional focus on Business Services companies.

Coverage Industries

IndustryPercentage
TECHNOLOGY SERVICES
1 company
20.0%
MEDICAL SERVICES
1 company
20.0%
SURGICAL & MEDICAL INSTRUMENTS
1 company
20.0%
MED - OUTP/HM CRE
1 company
20.0%
MED INSTRUMENTS
1 company
20.0%

Yuan Zhi's Ratings History at B. Riley

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
7/23/2025Reiterated Rating$21.55$22.00Buy
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
7/16/2025Initiated Coverage$2.97$6.00Buy
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
7/15/2025Upgrade$3.23Strong-Buy
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
6/23/2025Reiterated Rating$3.99$12.00Buy
RadNet, Inc. stock logo
RDNT
RadNet
6/13/2025Initiated Coverage$56.58$69.00Buy
Hyperfine, Inc. stock logo
HYPR
Hyperfine
5/15/2025Lower Price Target$0.60$1.00Buy
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
4/16/2025Lower Price Target$13.69$17.00Buy
Hyperfine, Inc. stock logo
HYPR
Hyperfine
3/20/2025Lower Price Target$0.85$1.20Buy